Jessica MontesJessicaMontes

Representation of multi-national medical device manufacturer in connection with a voluntary disclosure to the U.S. Department of Justice related to potential violations of the Foreign Corrupt Practices Act in China and various other jurisdictions

Representation of multi-national rare disease pharmaceutical company in connection with an investigation into potential violations of the Foreign Corrupt Practices Act in Europe, Japan, and Latin America by the U.S. Department of Justice and Securities and Exchange Commission

Representation of pharmaceutical company in connection with a U.S. Department of Justice subpoena and investigation into its patient support program, drug pricing, and specialty pharmacy relationships

Representation of pharmaceutical company in connection with a U.S. Department of Justice subpoena and investigation into manufacturer rebates to pharmacy benefit managers

Representation of a senior executive of a biopharmaceutical company in connection with a U.S. Department of Justice subpoena and investigation into donations to copay assistance charities

Representation of an opioid manufacturer in connection with a multi-district federal investigation and a qui tam complaint focusing on promotional practices and alleging potential violations of the anti-kickback statute and False Claims Act, resulting in a $7.55 million civil-only settlement in the District of New Jersey

Conducted internal investigation on behalf of a pharmaceutical company into whistleblower allegations of potential Anti-Kickback Statute violations related to company-sponsored clinical trials, investigator-initiated studies, and advisory boards